| selegiline | <chemical> A selective, irreversible inhibitor of type b monoamine oxidase. It is used in newly diagnosed patients with parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. The compound without isomeric designation is deprenyl. Pharmacological action: antiparkinson agents, monoamine oxidase inhibitors, neuroprotective agents. Chemical name: Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)- (12 Dec 1998) |
|---|